EFM
BSX icon

E Fund Management’s Boston Scientific BSX Stock Holding History

E Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Buy
11,657
+1,802
+18% +$97.8K 0.01% 266
2026
Q1 		$618K Buy
+9,855
New +$788K 0.02% 239
2025
Q2 		$692K Sell
6,442
-65,118
-91% -$6.59M 0.03% 198
2025
Q1 		$7.22M Sell
71,560
-15,288
-18% -$1.54M 0.34% 46
2024
Q4 		$7.76M Buy
86,848
+33,274
+62% +$2.93M 0.39% 36
2024
Q3 		$4.49M Buy
53,574
+49,164
+1,115% +$3.88M 0.23% 44
2024
Q2 		$340K Sell
4,410
-413
-9% -$30.2K 0.02% 218
2024
Q1 		$330K Buy
4,823
+216
+5% +$13.9K 0.02% 265
2023
Q4 		$266K Buy
4,607
+683
+17% +$36.5K 0.02% 248
2023
Q3 		$207K Sell
3,924
-302
-7% -$15.8K 0.02% 252
2023
Q2 		$229K Sell
4,226
-517
-11% -$27K 0.02% 262
2023
Q1 		$237K Sell
4,743
-327
-6% -$15.4K 0.02% 267
2022
Q4 		$235K Sell
5,070
-805
-14% -$34.9K 0.02% 273
2022
Q3 		$228K Buy
5,875
+382
+7% +$15.3K 0.02% 280
2022
Q2 		$205K Buy
5,493
+134
+3% +$5.46K 0.02% 295
2022
Q1 		$237K Sell
5,359
-766
-13% -$33.2K 0.01% 264
2021
Q4 		$260K Buy
6,125
+141
+2% +$5.92K 0.01% 226
2021
Q3 		$260K Buy
+5,984
New +$265K 0.01% 202

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

E Fund Management's BSX Position: Q2 2026 in Review

E Fund Management increased its Boston Scientific (BSX) stake by 18% in Q2 2026, buying an estimated $97.8K and bringing the position to 11,657 shares worth $498K. The position accounts for 0.01% of the portfolio, ranked #266.

E Fund Management first reported a position in BSX in Q3 2021 and has held it in 18 quarters since. The position peaked at $7.76M in Q4 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • E Fund Management held 11,657 shares of Boston Scientific worth $498K as of Q2 2026.
  • E Fund Management bought 1,802 Boston Scientific shares in Q2 2026, an estimated $97.8K.
  • Boston Scientific made up 0.01% of E Fund Management's portfolio in Q2 2026, its #266 holding.
  • E Fund Management first reported a position in Boston Scientific in Q3 2021 and has held it in 18 quarters since.
  • E Fund Management's Boston Scientific position peaked at $7.76M in Q4 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.